Stay updated with breaking news from Werner Gladdines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...
Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in June 28.05.2024 / 12:30 CET/CEST The issuer is solely responsible
Immunic Inc (NASDAQ:IMUX) will be present at two conferences in June. At the BIO International Convention in San Diego, Jessica Breu, VP of Investor...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Issuer: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Upcoming Investor and Industry Conferences 25.04.2022...